Hellenbrand, Daniel J.
Reichl, Kaitlyn A.
Travis, Benjamin J.
Filipp, Mallory E.
Khalil, Andrew S.
Pulito, Domenic J.
Gavigan, Ashley V.
Maginot, Elizabeth R.
Arnold, Mitchell T.
Adler, Alexander G.
Murphy, William L.
Hanna, Amgad S.
Funding for this research was provided by:
Bryon Riesch Paralysis Foundation (133-PRJ84LQ)
Fraternal Order of Eagles (133-PRJ84LQ)
Article History
Received: 20 December 2018
Accepted: 9 April 2019
First Online: 30 April 2019
Ethics approval and consent to participate
: All experimental procedures were performed following the National Institutes of Health Guide for the care and use of laboratory animals and in accordance with protocols approved by the University of Wisconsin–Madison Animal Use & Care Committee.
: Not applicable.
: W.L.M. is a co-founder and stockholder of Dianomi Therapeutics. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.